Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -16.720\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
[a] Cc1cc(C)cc(C(=O)n2cnnc2N)c1
[b] O=C(COC(=O)C12CC3CC(CC(O)(C3)C1)C2)NC(=O)NCc1ccco1
[c] Cc1ccc(N(CC(=O)NCC2CCCO2)S(=O)(=O)c2ccccc2)c(C)c1
[d] O=C(c1ccc2nc[nH]c2c1)N1CCN(c2ncc(C(F)(F)F)cc2Cl)CC1
[e] O=C1C2CCCCN2C(=O)N1CCCCN1CCN(c2cccc(Br)c2)CC1
Answer: e. O=C1C2CCCCN2C(=O)N1CCCCN1CCN(c2cccc(Br)c2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C1C2CCCCN2C(=O)N1CCCCN1CCN(c2cccc(Br)c2)CC1
O=C1C2CCCCN2C(=O)N1CCCCN1CCN(c2cccc(Br)c2)CC1
2-[4-[4-(3-bromophenyl)piperazin-1-yl]butyl]-6,7,8,8a-tetrahydro-5H-imidazo[1,5-a]pyridine-1,3-dione